{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:28:18Z","timestamp":1790440098643,"version":"4.1.0"},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"vor","delay-in-days":1736,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T00:00:00Z","timestamp":1616198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Institut national pour la sant\u00e9 et la recherche m\u00e9dicale"},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"name":"COST ADMIRE Network","award":["BM1301"],"award-info":[{"award-number":["BM1301"]}]},{"DOI":"10.13039\/100007369","name":"Institut de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007369","name":"Institut de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007369","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>In post-menopausal women, incidence of heart failure with preserved ejection fraction is higher than in men. Hormonal replacement therapies did not demonstrate benefits. We tested whether the non-steroidal mineralocorticoid receptor antagonist finerenone limits the progression of heart failure in ovariectomized (OVX) mice with metabolic disorders.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Ovariectomy was performed in 4-month-old mice, treated or not at 7 months old for 1 month with finerenone (Fine) 1 mg\/kg\/day. Left ventricular (LV) cardiac and coronary endothelial functions were assessed by echocardiography, catheterization, and myography. Blood pressure was measured by plethysmography. Insulin and glucose tolerance tests were performed. Exercise capacity and spontaneous activity were measured on treadmill and in combined indirect calorimetric cages equipped with voluntary running wheel. OVX mice presented LV diastolic dysfunction without modification of ejection fraction compared with controls (CTL), whereas finerenone improved LV filling pressure (LV end-diastolic pressure, mmHg: CTL 3.48 \u00b1 0.41, OVX 6.17 \u00b1 0.30**, OVX + Fine 3.65 \u00b1 0.55\u2020, **P &amp;lt; 0.01 vs. CTL, \u2020P &amp;lt; 0.05 vs. OVX) and compliance (LV end-diastolic pressure\u2013volume relation, mmHg\/RVU: CTL 1.65 \u00b1 0.42, OVX 4.77 \u00b1 0.37***, OVX + Fine 2.87 \u00b1 0.26\u2020\u2020, ***P &amp;lt; 0.001 vs. CTL, \u2020\u2020P &amp;lt; 0.01 vs. OVX). Acetylcholine-induced endothelial-dependent relaxation of coronary arteries was impaired in ovariectomized mice and improved by finerenone (relaxation, %: CTL 86 \u00b1 8, OVX 38 \u00b1 3**, OVX + Fine 83 \u00b1 7\u2020\u2020, **P &amp;lt; 0.01 vs. CTL, \u2020\u2020P &amp;lt; 0.01 vs. OVX). Finerenone improved decreased ATP production by subsarcolemmal mitochondria after ovariectomy. Weight gain, increased blood pressure, and decreased insulin and glucose tolerance in OVX mice were improved by finerenone. The exercise capacity at race was diminished in untreated OVX mice only. Spontaneous activity measurements in ovariectomized mice showed decreased horizontal movements, reduced time spent in a running wheel, and reduced VO2 and VCO2, all parameters improved by finerenone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Finerenone improved cardiovascular dysfunction and exercise capacity after ovariectomy-induced LV diastolic dysfunction with preserved ejection fraction.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.13219","type":"journal-article","created":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T04:40:55Z","timestamp":1616215255000},"page":"1933-1943","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Mineralocorticoid Receptor Blockade with Finerenone Improves Heart Function and Exercise Capacity in Ovariectomized Mice"],"prefix":"10.1093","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2933-3557","authenticated-orcid":false,"given":"Marie","family":"Pieronne-Deperrois","sequence":"first","affiliation":[{"name":"Inserm U1096 ENVI, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Gu\u00e9ret","sequence":"additional","affiliation":[{"name":"Inserm U1096 ENVI, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoubir","family":"Djerada","sequence":"additional","affiliation":[{"name":"Pharmacology Department, Reims University Hospital , Reims ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Crochemore","sequence":"additional","affiliation":[{"name":"EA4651 Toxemac-ABTE, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najah","family":"Harouki","sequence":"additional","affiliation":[{"name":"Inserm U1096 ENVI, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Paul","family":"Henry","sequence":"additional","affiliation":[{"name":"Inserm U1096 ENVI, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana\u00efs","family":"Dumesnil","sequence":"additional","affiliation":[{"name":"Inserm U1096 ENVI, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Larchev\u00eaque","sequence":"additional","affiliation":[{"name":"Inserm U1096 ENVI, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"do Rego","sequence":"additional","affiliation":[{"name":"SCAC Behavioral Analysis Platform, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"do Rego","sequence":"additional","affiliation":[{"name":"SCAC Behavioral Analysis Platform, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lionel","family":"Nicol","sequence":"additional","affiliation":[{"name":"Inserm U1096 ENVI, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Richard","sequence":"additional","affiliation":[{"name":"Inserm U1096 ENVI, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Jaisser","sequence":"additional","affiliation":[{"name":"Inserm U1138, Cordeliers Institute, Paris-VI University , Paris ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kolkhof","sequence":"additional","affiliation":[{"name":"Bayer AG , Wuppertal ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Mulder","sequence":"additional","affiliation":[{"name":"Inserm U1096 ENVI, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Monteil","sequence":"additional","affiliation":[{"name":"EA4651 Toxemac-ABTE, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Ouvrard-Pascaud","sequence":"additional","affiliation":[{"name":"Inserm U1096 ENVI, Rouen Medical School, UNIROUEN, Normandy University , Rouen ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,3,20]]},"reference":[{"key":"2026012114030835100_ehf213219-bib-0001","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2026012114030835100_ehf213219-bib-0002","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"2026012114030835100_ehf213219-bib-0003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N Engl J Med"},{"key":"2026012114030835100_ehf213219-bib-0004","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCULATIONAHA.114.013255","article-title":"Regional variation in patients and outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) trial","volume":"131","author":"Pfeffer","year":"2015","journal-title":"Circulation"},{"key":"2026012114030835100_ehf213219-bib-0005","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1056\/NEJMc1612601","article-title":"Spironolactone metabolites in TOPCAT\u2014new insights into regional variation","volume":"376","author":"de Denus","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012114030835100_ehf213219-bib-0006","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/cmdc.201200081","article-title":"Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases","volume":"7","author":"B\u00e4rfacker","year":"2012","journal-title":"ChemMedChem"},{"key":"2026012114030835100_ehf213219-bib-0007","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1093\/eurheartj\/eht187","article-title":"Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial","volume":"34","author":"Pitt","year":"2013","journal-title":"Eur Heart J"},{"key":"2026012114030835100_ehf213219-bib-0008","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1093\/eurheartj\/ehw132","article-title":"A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and\/or chronic kidney disease","volume":"37","author":"Filippatos","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012114030835100_ehf213219-bib-0009","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1161\/HYPERTENSIONAHA.110.152975","article-title":"Postmenopausal hypertension: role of the renin-angiotensin system","volume":"56","author":"Yanes","year":"2010","journal-title":"Hypertension"},{"key":"2026012114030835100_ehf213219-bib-0010","article-title":"Characterization of the cardiac renin angiotensin system in oophorectomized and estrogen-replete mRen2.Lewis rats","volume":"8","author":"Wang","year":"2013","journal-title":"PLoS ONE"},{"key":"2026012114030835100_ehf213219-bib-0011","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1161\/HYPERTENSIONAHA.111.180976","article-title":"Effects of estrogen on cardiovascular injury in ovariectomized female DahlS.Z-Lepr (fa)\/Lepr (fa) rats as a new animal model of metabolic syndrome","volume":"59","author":"Murase","year":"2012","journal-title":"Hypertension"},{"key":"2026012114030835100_ehf213219-bib-0012","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13912","article-title":"Effects of hypoestrogenism and\/or hyperaldosteronism on myocardial remodeling in female mice","volume":"6","author":"Rouet-Benzineb","year":"2018","journal-title":"Physiol Rep"},{"key":"2026012114030835100_ehf213219-bib-0013","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1139\/cjpp-2018-0416","article-title":"Ameliorative effect of low-dose spironolactone on obesity and insulin resistance is through replenishment of estrogen in ovariectomized rats","volume":"97","author":"Olatunji","year":"2019","journal-title":"Can J Physiol Pharmacol"},{"key":"2026012114030835100_ehf213219-bib-0014","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007675","article-title":"Sex-specific mechanisms of resistance vessel endothelial dysfunction induced by cardiometabolic risk factors","volume":"7","author":"Davel","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026012114030835100_ehf213219-bib-0015","first-page":"825","article-title":"Sex differences in cardiovascular ageing","volume":"102","author":"Merz","year":"2016","journal-title":"Heart Br Card Soc"},{"key":"2026012114030835100_ehf213219-bib-0016","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/jama.1996.03530440037034","article-title":"The progression from hypertension to congestive heart failure","volume":"275","author":"Levy","year":"1996","journal-title":"JAMA"},{"key":"2026012114030835100_ehf213219-bib-0017","doi-asserted-by":"crossref","first-page":"R1220","DOI":"10.1152\/ajpregu.00864.2007","article-title":"Sex and the renin-angiotensin system: inequality between the sexes in response to RAS stimulation and inhibition","volume":"294","author":"Sullivan","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"2026012114030835100_ehf213219-bib-0018","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0002-9149(74)90089-7","article-title":"Role of diabetes in congestive heart failure: the Framingham study","volume":"34","author":"Kannel","year":"1974","journal-title":"Am J Cardiol"},{"key":"2026012114030835100_ehf213219-bib-0019","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1161\/HYPERTENSIONAHA.115.05674","article-title":"Low-dose mineralocorticoid receptor blockade prevents Western diet-induced arterial stiffening in female mice","volume":"66","author":"DeMarco","year":"2015","journal-title":"Hypertension"},{"key":"2026012114030835100_ehf213219-bib-0020","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2006.09.032","article-title":"Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies","volume":"49","author":"Gami","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2026012114030835100_ehf213219-bib-0021","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1161\/01.CIR.95.1.252","article-title":"Sex differences in coronary heart disease. why are women so superior? The 1995 Ancel Keys Lecture","volume":"95","author":"Barrett-Connor","year":"1997","journal-title":"Circulation"},{"key":"2026012114030835100_ehf213219-bib-0022","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000237742","article-title":"Predictors of hyperkalemia risk following hypertension control with aldosterone blockade","volume":"30","author":"Khosla","year":"2009","journal-title":"Am J Nephrol"},{"key":"2026012114030835100_ehf213219-bib-0023","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.119.044491","article-title":"Effects of sacubitril-valsartan versus valsartan in women compared with men with heart failure and preserved ejection fraction: insights from PARAGON-HF","volume":"141","author":"McMurray","year":"2020","journal-title":"Circulation"},{"key":"2026012114030835100_ehf213219-bib-0024","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.jchf.2019.01.003","article-title":"Sex differences in outcomes and responses to spironolactone in heart failure with preserved ejection fraction: a secondary analysis of TOPCAT trial","volume":"7","author":"Merrill","year":"2019","journal-title":"JACC Heart Fail"},{"key":"2026012114030835100_ehf213219-bib-0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/CS20070166","article-title":"Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome","volume":"114","author":"Bugger","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"2026012114030835100_ehf213219-bib-0026","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mito.2017.05.011","article-title":"Estrogen regulates spatially distinct cardiac mitochondrial subpopulations","volume":"35","author":"Ribeiro Junior","year":"2017","journal-title":"Mitochondrion"},{"key":"2026012114030835100_ehf213219-bib-0027","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.yjmcc.2018.06.008","article-title":"Mineralocorticoid receptor antagonism improves diastolic dysfunction in chronic kidney disease in mice","volume":"121","author":"Bonnard","year":"2018","journal-title":"J Mol Cell Cardiol"},{"key":"2026012114030835100_ehf213219-bib-0028","doi-asserted-by":"crossref","first-page":"H1101","DOI":"10.1152\/ajpheart.00660.2005","article-title":"Regulatory role of ovarian sex hormones in calcium uptake activity of cardiac sarcoplasmic reticulum","volume":"291","author":"Bupha-Intr","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026012114030835100_ehf213219-bib-0029","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3389\/fphys.2018.01545","article-title":"Passive stiffness of left ventricular myocardial tissue is reduced by ovariectomy in a post-menopause mouse model","volume":"9","author":"Farr\u00e9","year":"2018","journal-title":"Front Physiol"},{"key":"2026012114030835100_ehf213219-bib-0030","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3389\/fphar.2018.01131","article-title":"Finerenone attenuates endothelial dysfunction and albuminuria in a chronic kidney disease model by a reduction in oxidative stress","volume":"9","author":"Gonz\u00e1lez-Bl\u00e1zquez","year":"2018","journal-title":"Front Pharmacol"},{"key":"2026012114030835100_ehf213219-bib-0031","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000506275","article-title":"Finerenone reduces intrinsic arterial stiffness in Munich Wistar Fr\u00f6mter rats, a genetic model of chronic kidney disease","volume":"51","author":"Gil-Ortega","year":"2020","journal-title":"Am J Nephrol"},{"key":"2026012114030835100_ehf213219-bib-0032","article-title":"Hormonal therapy with estradiol and drospirenone improves endothelium-dependent vasodilation in the coronary bed of ovariectomized spontaneously hypertensive rats","volume":"49","author":"Borgo","year":"2016","journal-title":"Braz J Med Biol Res Rev Bras Pesqui Medicas E Biol"},{"key":"2026012114030835100_ehf213219-bib-0033","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/HYPERTENSIONAHA.115.06709","article-title":"Vascular smooth muscle mineralocorticoid receptor contributes to coronary and left ventricular dysfunction after myocardial infarction","volume":"67","author":"Gueret","year":"2016","journal-title":"Hypertension"},{"key":"2026012114030835100_ehf213219-bib-0034","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2147\/CIA.S88441","article-title":"Impact of aging on cardiac function in a female rat model of menopause: role of autonomic control, inflammation, and oxidative stress","volume":"11","author":"Machi","year":"2016","journal-title":"Clin Interv Aging"},{"key":"2026012114030835100_ehf213219-bib-0035","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1037\/h0033526","article-title":"Ovarian-adrenal interactions in regulation of body weight by female rats","volume":"81","author":"Mook","year":"1972","journal-title":"J Comp Physiol Psychol"},{"key":"2026012114030835100_ehf213219-bib-0036","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/j.1749-6632.1994.tb39273.x","article-title":"The effects of RU 38486 and RU 28318 on energy balance of ovariectomized rats","volume":"746","author":"Dagnault","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"2026012114030835100_ehf213219-bib-0037","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1161\/CIRCULATIONAHA.115.018226","article-title":"Adipocyte-derived hormone leptin is a direct regulator of aldosterone secretion, which promotes endothelial dysfunction and cardiac fibrosis","volume":"132","author":"Huby","year":"2015","journal-title":"Circulation"},{"key":"2026012114030835100_ehf213219-bib-0038","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1161\/HYPERTENSIONAHA.115.06642","article-title":"Leptin induces hypertension and endothelial dysfunction via aldosterone-dependent mechanisms in obese female mice","volume":"67","author":"Huby","year":"2016","journal-title":"Hypertension"},{"key":"2026012114030835100_ehf213219-bib-0039","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11010-020-03879-4","article-title":"Ovariectomized rodents as a menopausal metabolic syndrome model","volume":"475","author":"Medina-Contreras","year":"2020","journal-title":"A minireview Mol Cell Biochem"},{"key":"2026012114030835100_ehf213219-bib-0040","doi-asserted-by":"crossref","first-page":"12450","DOI":"10.1096\/fj.202000164R","article-title":"The novel non-steroidal MR antagonist finerenone improves metabolic parameters in high-fat diet-fed mice and activates brown adipose tissue via AMPK-ATGL pathway","volume":"34","author":"Marzolla","year":"2020","journal-title":"FASEB J"},{"key":"2026012114030835100_ehf213219-bib-0041","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jsbmb.2014.11.009","article-title":"Significant role of estrogen in maintaining cardiac mitochondrial functions","volume":"147","author":"Rattanasopa","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"2026012114030835100_ehf213219-bib-0042","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.lfs.2018.09.034","article-title":"Increased sleep time and reduced energy expenditure contribute to obesity after ovariectomy and a high fat diet","volume":"212","author":"Do Carmo","year":"2018","journal-title":"Life Sci"},{"key":"2026012114030835100_ehf213219-bib-0043","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/CIRCHEARTFAILURE.109.877720","article-title":"Impaired heart rate recovery and chronotropic incompetence in patients with heart failure with preserved ejection fraction","volume":"3","author":"Phan","year":"2010","journal-title":"Circ Heart Fail"},{"key":"2026012114030835100_ehf213219-bib-0044","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1677\/joe.0.0840371","article-title":"Interaction of spironolactone with oestradiol receptors in cytosol","volume":"84","author":"Levy","year":"1980","journal-title":"J Endocrinol"},{"key":"2026012114030835100_ehf213219-bib-0045","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/eurjhf\/hfs061","article-title":"Rationale and design of ARTS: a randomized, double-blind study of BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease","volume":"14","author":"Pitt","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026012114030835100_ehf213219-bib-0046","doi-asserted-by":"crossref","first-page":"21876","DOI":"10.1074\/jbc.M115.657957","article-title":"Finerenone impedes aldosterone-dependent nuclear import of the mineralocorticoid receptor and prevents genomic recruitment of steroid receptor coactivator-1","volume":"290","author":"Amazit","year":"2015","journal-title":"J Biol Chem"},{"key":"2026012114030835100_ehf213219-bib-0047","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1161\/HYPERTENSIONAHA.117.10360","article-title":"Selective mineralocorticoid receptor cofactor modulation as molecular basis for finerenone's antifibrotic activity","volume":"71","author":"Grune","year":"2018","journal-title":"Hypertension"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.13219","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.13219","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/3\/1933\/65798048\/eschf_8_3_1933.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/8\/3\/1933\/65798048\/eschf_8_3_1933.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T19:03:22Z","timestamp":1769022202000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/8\/3\/1933\/8363479"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,20]]},"references-count":47,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,3,20]]},"published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.13219","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,6]]},"published":{"date-parts":[[2021,3,20]]},"assertion":[{"value":"2020-07-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-01-06","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}